Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries.
Saved in:
| Title: | Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries. |
|---|---|
| Authors: | Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland., Salwender H; Department of Internal Medicine II, Asklepios Klinik Altona, 22763 Hamburg, Germany., Martin H; Department of Medicine, Hematology/Oncology, Goethe-University of Frankfurt, 60590 Frankfurt, Germany., Scheid C; Department I of Internal Medicine, University of Cologne, 50923 Köln, Germany., Hielscher T; Abteilung für Biostatistik, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany., Bertsch U; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany., Hummel M; Abteilung für Biostatistik, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany., Jauch A; Institut für Humangenetik, Universität Heidelberg, 69120 Heidelberg, Germany., Knauf W; Onkologische Gemeinschaftspraxis, Agaplesion Bethanien Krankenhaus, 60389 Frankfurt, Germany., Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium., Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium., Neben K; Klinikum Mittelbaden, Medizinische Klinik 2, 76530 Baden-Baden, Germany., Dührig J; Katholisches Krankenhaus Hagen, 58099 Hagen, Germany., Lindemann W; Department of Hematology, University Hospital Essen, 45147 Essen, Germany., Schmidt-Wolf IGH; Department of Integrated Oncology, CIO Bonn, University of Bonn, 53127 Bonn, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz GmbH, 09113 Chemnitz, Germany., Blau IW; Medical Clinic III Hematology and Oncology, Charité University Medicine Berlin, 13353 Berlin, Germany., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Weinhold N; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany., Raab MS; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany., Goldschmidt H; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, 69120 Heidelberg, Germany., Choon-Quinones M; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland., Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2024 Jun 11; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 11. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms25126431 |
